Skip to main content
SpringerLink
Log in

Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC)

  • Short Communication
  • Published:
Journal of Inherited Metabolic Disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Edelmann Jr CM, Soriano JR, Boichis H, Gruskin AB, Acosta MI (1967) Renal bicarbonate reabsorption and hydrogen ion excretion in normal infants.J Clin Invest 46: 1309–1317.

    Google Scholar 

  • Gibbs TC, Payan J, Brett EM, Lindstedt S, Holme E, Clayton P (1993) Peripheral neuropathy as the presenting feature of tyrosinemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase.J Neurol Neurosurg Psychiatry 56: 1129–1132.

    Google Scholar 

  • Kvittingen EA, Talseth T, Halvorsen S, Jakobs C, Hovig T, Flatmark A (1991) Renal failure in adult patients with hereditary tyrosinaemia type I.J Inher Metab Dis 14: 53–62.

    Google Scholar 

  • Laine J, Salo MK, Krogerus L, Kärkkäinen J, Wahlroos Ö, Holmberg C (1995) The nephropathy of type I tyrosinemia after liver transplantation.Pediatr Res 37: 640–645.

    Google Scholar 

  • Lindstedt S, Holme E, Lock EA, Hjalmarsson O, Strandvik B (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.Lancet 340: 813–817.

    Google Scholar 

  • McKiernan PJ, Preece MA, Green A, et al (1994) Successful treatment of life threatening neurological crises in tyrosinaemia type 1 with NTBC.Proc 32nd SSIEM Annual Symposium, Edinburgh, Oral presentation 11.

  • Mitchell GA, Lambert M, Tanguay RM (1995) Hypertyrosinemia. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds.The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1077–1106.

    Google Scholar 

  • Shoemaker LR, Strife F, Balistreri WF, Ruckman FC (1992) Rapid improvement in the renal tubular dysfunction associated with tyrosinemia following hepatic replacement.Pediatrics 89: 251–255.

    Google Scholar 

  • van Spronson FJ, Thomasse Y, Smit GPA, et al (1994) Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment.Hepatology 20: 1187–1191.

    Google Scholar 

  • Tuchman M, Freese DK, Sharp HL, et al (1987) Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.J Pediatr 110: 399–403.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Metabolic Diseases, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, Warsaw, Poland

    E. Pronicka, E. Rowinska, Z. Bentkowski & J. Zawadzki

  2. Department of Clinical Chemistry, Gothenburg University, Sahlgren's University Hospital, Sweden

    E. Holme & S. Lindstedt

Authors
  1. E. Pronicka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Rowinska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Z. Bentkowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Zawadzki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Holme
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Lindstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pronicka, E., Rowinska, E., Bentkowski, Z. et al. Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC). J Inherit Metab Dis 19, 234–238 (1996). https://doi.org/10.1007/BF01799438

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01799438

Keywords

Search

Navigation